Q3 2025 WELL Health Technologies Corp Earnings Call Transcript
Key Points
- WELL Health Technologies Corp (WHTCF) reported a significant revenue increase of 56% year-over-year, reaching approximately $365 million for Q3 2025.
- The company achieved a remarkable growth in adjusted EBITDA, which increased by 296% to $59.9 million compared to the previous year.
- WELL Health Technologies Corp (WHTCF) improved its gross margins by 510 basis points to 45.5% from 40.4% last year.
- The Canadian clinics business showed strong performance with a compound annual growth rate exceeding 50% over the past four years.
- WELL Health Technologies Corp (WHTCF) has a robust M&A pipeline, with approximately $235 million in clinics under letters of intent (LOI), indicating strong future growth potential.
- Circle Medical's patient visits were lower than last year due to a significant focus on compliance, impacting overall system-wide organic growth.
- The strategic review process for US assets, including Circle Medical, is expected to take longer, potentially delaying divestment plans.
- Free cash flow attributable to shareholders decreased slightly to $15.1 million in Q3 2025 from $16.1 million in Q3 of last year.
- The company incurred a $10.5 million impairment charge related to the divestment of HealWell's clinical operations.
- There is a slower organic growth in patient visits system-wide, attributed to Circle Medical's compliance focus, which could affect future revenue growth.
Good afternoon ladies and gentlemen, and welcome to the World Health Technologies Corp 3rd quarter 2025 earnings release conference call.
At this time, all lines are in listen-only mode. Following the presentation, we will conduct a question-and-answer session. If at any time during this call you need assistance, please press 0 for the operator. This call is being recorded on Thursday, November 6, 2025. I would now turn the conference over to Tyler Baba, investor relations manager. Please go ahead.
Thank you operator, and welcome everyone to Wi House fiscal 3rd quarter financial results conference call for the 3 months ended September 30th, 2025.
Joining me on the call today are Hamad Shahbazi, Chairman and CEO, and Eva Fong, the company's CFO. I trust that everyone has received a copy of our financial results press release that was issued earlier today.
Portions of today's call, other than historical performance include statements of forward-looking information
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

